Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

NCT02869633

Conditions
Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 239524 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 225300 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 240820 Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital /ID# 227433 Toyohashi, Aichi-ken, Japan
View all 102 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT05338892

Conditions
Chronic Disease, Diffuse Large B-cell Lymphoma, Disease Attributes, +20 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details
Completed

A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02005471

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of California San Diego Medical Center La Jolla, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center; Clinical Trials Office New York, United States
  • Perlmutter Cancer Center NYU Langone Health New York, United States
View all 111 locations
View Trial Details
Completed

Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

NCT01000753

Conditions
Adult Immunoblastic Lymphoma, Central Nervous System Non-Hodgkin Lymphoma, Childhood Immunoblastic Lymphoma, +35 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 130 locations
View Trial Details

Related conditions